Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kingsdale Capital Markets was a Toronto-based boutique investment bank and brokerage firm that provided financial services to small and mid-cap companies. The firm was particularly active in the Canadian capital markets, offering expertise in investment banking, institutional sales and trading, and corporate finance advisory for sectors including life sciences, technology, and natural resources. While not a drug development company, it facilitated significant financing rounds and advisory services for various biotechnology firms in Canada. The company was a member of the Investment Industry Regulatory Organization of Canada (IIROC) until its operations were suspended in late 2015. It was part of the broader Kingsdale group, which is well-known for its proxy solicitation and shareholder services arm, Kingsdale Advisors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kingsdale Capital Markets.